KEY FEATURES
| Full Name | Colony Stimulating Factor 2 Receptor Beta |
|---|---|
| Synonym | CD131; CSF2R-B; IL3-RB; IL3RB; CSF2-RB; Colony Stimulating Factor 2 Receptor,Beta,Low-Affinity(granulocyte-Macrophage); GM-CSF/IL-3/IL-5 receptor common beta subunit |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CSF2Rb in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CSF2Rb. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CSF2Rb and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CSF2Rb, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CSF2Rb. You can calculate the concentration of Human CSF2Rb in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CSF2Rb ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.98 | 3.04 | 9.95 | 0.98 | 3 | 9.63 |
| Standard deviation | 0.07 | 0.15 | 0.55 | 0.06 | 0.16 | 0.33 |
| CV(%) | 6.84 | 4.94 | 5.49 | 6.49 | 5.47 | 3.42 |
RECOVERY
The recovery of Human CSF2Rb spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 85-97 | 92 |
| EDTA plasma (n=8) | 87-97 | 92 |
| Cell culture media (n=8) | 92-108 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CSF2Rb in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CSF2Rb ELISA Kits
| IL5RA ELISA Kit | publications with CSF2Rb and IL5RA |
| JAK2 ELISA Kit | publications with CSF2Rb and JAK2 |
| IL3 ELISA Kit | publications with CSF2Rb and IL3 |
| CSF2 ELISA Kit | publications with CSF2Rb and CSF2 |
| CSF2RA ELISA Kit | publications with CSF2Rb and CSF2RA |
| LYN ELISA Kit | publications with CSF2Rb and LYN |
| IL5 ELISA Kit | publications with CSF2Rb and IL5 |
| SHC1 ELISA Kit | publications with CSF2Rb and SHC1 |
| PTPN11 ELISA Kit | publications with CSF2Rb and PTPN11 |
Pathways associated with CSF2Rb ELISA Kit
| Apoptosis Pathway | Apoptosis Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| G Beta:gamma Signalling Through PI3Kgamma Pathway | G Beta:gamma Signalling Through PI3Kgamma Pathway |
| G-protein Beta:gamma Signalling Pathway | G-protein Beta:gamma Signalling Pathway |
| GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
| GPVI-mediated Activation Cascade Pathway | GPVI-mediated Activation Cascade Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
Diseases associated with CSF2Rb ELISA Kit
| Inflammation | publications with CSF2Rb and Inflammation |
| Disease Models, Animal | publications with CSF2Rb and Disease Models, Animal |
| Lung Diseases | publications with CSF2Rb and Lung Diseases |
| Respiratory Tract Diseases | publications with CSF2Rb and Respiratory Tract Diseases |
| Asthma | publications with CSF2Rb and Asthma |
| Necrosis | publications with CSF2Rb and Necrosis |
| Liver Diseases | publications with CSF2Rb and Liver Diseases |
| Heart Diseases | publications with CSF2Rb and Heart Diseases |
| Neoplasms, Experimental | publications with CSF2Rb and Neoplasms, Experimental |
| Liver Neoplasms | publications with CSF2Rb and Liver Neoplasms |
Organs/Tissues associated with CSF2Rb ELISA Kit
| Blood | publications with CSF2Rb and Blood |
| Bone | publications with CSF2Rb and Bone |
| Bone Marrow | publications with CSF2Rb and Bone Marrow |
| Lung | publications with CSF2Rb and Lung |
| Vascular | publications with CSF2Rb and Vascular |
| Brain | publications with CSF2Rb and Brain |
| Skin | publications with CSF2Rb and Skin |
| Intestine | publications with CSF2Rb and Intestine |
| Muscle | publications with CSF2Rb and Muscle |
| Lymph Node | publications with CSF2Rb and Lymph Node |